comparemela.com

Latest Breaking News On - Managing director krishna - Page 1 : comparemela.com

Ocugen, Bharat Biotech COVID vaccine shows better safety/efficacy in kids vs adults

Ocugen (OCGN) said interim data from phase 2/3 trial of Covaxin, developed by India's Bharat Biotech, was published in a journal and mentioned that the COVID-19 vaccine showed efficacy.

astrazeneca vaccine: অ্যাস্ট্রাজেনেকার তৈরি টিকা নিয়েই মহিলার মৃত্যু, কী বলছেন বিশেষজ্ঞরা? - a woman from canada dies after receiving astrazeneca vaccine

astrazeneca vaccine: অ্যাস্ট্রাজেনেকার তৈরি টিকা নিয়েই মহিলার মৃত্যু, কী বলছেন বিশেষজ্ঞরা? - a woman from canada dies after receiving astrazeneca vaccine
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Bharat Biotech s Covaxin to cost Rs 600 for state govts, Rs 1,200 for pvt hospitals

Bharat Biotech s Covaxin to cost Rs 600 for state govts, Rs 1,200 for pvt hospitals
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

Bharat Biotech s Covaxin to cost Rs 600 for state govts, Rs 1,200 for pvt hospitals

Bharat Biotech s Covaxin to cost Rs 600 for state govts, Rs 1,200 for pvt hospitals
origin-businesstoday.intoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from origin-businesstoday.intoday.in Daily Mail and Mail on Sunday newspapers.

covid 19 vaccine: টিকা নিলে সংক্রমণ-ভয়াবহতা কম, পরিসংখ্যান প্রকাশ কেন্দ্রের - people who have taken two doses of covid vaccine have less chance of getting infected

covid 19 vaccine: টিকা নিলে সংক্রমণ-ভয়াবহতা কম, পরিসংখ্যান প্রকাশ কেন্দ্রের - people who have taken two doses of covid vaccine have less chance of getting infected
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.